PMC:7160614 / 6476-6706 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"129","span":{"begin":3,"end":10},"obj":"Species"}],"attributes":[{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"he patient recruitment pathway for the control group, along with the inclusion and exclusion criteria.\nAccording to previous studies [19–21], whose sample size is comparable with ours, the ratio between primary and validation coho"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":47,"end":52},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"he patient recruitment pathway for the control group, along with the inclusion and exclusion criteria.\nAccording to previous studies [19–21], whose sample size is comparable with ours, the ratio between primary and validation coho"}

{"project":"0_colil","denotations":[{"id":"32300971-29948074-67436","span":{"begin":134,"end":136},"obj":"29948074"},{"id":"32300971-30093881-67436","span":{"begin":134,"end":136},"obj":"30093881"},{"id":"32300971-30546304-67436","span":{"begin":134,"end":136},"obj":"30546304"}],"text":"he patient recruitment pathway for the control group, along with the inclusion and exclusion criteria.\nAccording to previous studies [19–21], whose sample size is comparable with ours, the ratio between primary and validation coho"}

{"project":"TEST0","denotations":[{"id":"32300971-31-37-67436","span":{"begin":134,"end":136},"obj":"[\"29948074\", \"30093881\", \"30546304\"]"}],"text":"he patient recruitment pathway for the control group, along with the inclusion and exclusion criteria.\nAccording to previous studies [19–21], whose sample size is comparable with ours, the ratio between primary and validation coho"}

{"project":"2_test","denotations":[{"id":"32300971-29948074-29373584","span":{"begin":134,"end":136},"obj":"29948074"},{"id":"32300971-30093881-29373584","span":{"begin":134,"end":136},"obj":"30093881"},{"id":"32300971-30546304-29373584","span":{"begin":134,"end":136},"obj":"30546304"}],"text":"he patient recruitment pathway for the control group, along with the inclusion and exclusion criteria.\nAccording to previous studies [19–21], whose sample size is comparable with ours, the ratio between primary and validation coho"}

{"project":"MyTest","denotations":[{"id":"32300971-29948074-29373584","span":{"begin":134,"end":136},"obj":"29948074"},{"id":"32300971-30093881-29373584","span":{"begin":134,"end":136},"obj":"30093881"},{"id":"32300971-30546304-29373584","span":{"begin":134,"end":136},"obj":"30546304"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"he patient recruitment pathway for the control group, along with the inclusion and exclusion criteria.\nAccording to previous studies [19–21], whose sample size is comparable with ours, the ratio between primary and validation coho"}